Literature DB >> 22110305

Ceftriaxone associated urolithiasis in a child with hypercalciuria.

V J Lozanovski, Z Gucev, V J Avramoski, I Kirovski, P Makreski, V Tasic.   

Abstract

We present a 5-year-old boy with pneumonia who complained of right lumbar pain on the 7(th) day of treatment with Ceftriaxone. Ultrasound examination revealed mild to moderate right hydronephrosis. Under spasmoanalgetic therapy and hydration there was spontaneous passage of three small calculi. Infrared spectroscopy showed that the calculi were composed of calcium-ceftriaxonate. Full metabolic investigation was performed and moderate hypercalciuria was detected, suggesting the role of hypercalciuria in ceftriaxone-associated nephrolithiasis.

Entities:  

Keywords:  biliary pseudolithiasis; ceftriaxone; child; hypercalciuria; infrared spectroscopy; urolithiasis

Year:  2011        PMID: 22110305      PMCID: PMC3209686     

Source DB:  PubMed          Journal:  Hippokratia        ISSN: 1108-4189            Impact factor:   0.471


  16 in total

1.  Ceftriaxone-associated nephrolithiasis.

Authors:  P Cochat; N Cochat; M Jouvenet; D Floret; C Wright; X Martin; J J Vallon; L David
Journal:  Nephrol Dial Transplant       Date:  1990       Impact factor: 5.992

2.  Ceftriaxone associated nephrolithiasis: a prospective study in 284 children.

Authors:  Masoumeh Mohkam; Abdollah Karimi; Atoosa Gharib; Hamid Daneshmand; Alireza Khatami; Nozar Ghojevand; Mostafa Sharifian
Journal:  Pediatr Nephrol       Date:  2007-01-17       Impact factor: 3.714

3.  Reversible ceftriaxone-associated biliary pseudolithiasis in children.

Authors:  U B Schaad; J Wedgwood-Krucko; H Tschaeppeler
Journal:  Lancet       Date:  1988-12-17       Impact factor: 79.321

4.  Incidence of ceftriaxone-associated gallbladder pseudolithiasis.

Authors:  F Papadopoulou; S Efremidis; S Karyda; M Badouraki; E Karatza; C Panteliadis; K Malaka
Journal:  Acta Paediatr       Date:  1999-12       Impact factor: 2.299

5.  Nephrolithiasis in a child with acute pyelonephritis. Ceftriaxone-induced nephrolithiasis and biliary pseudolithiasis.

Authors:  Velibor Tasic; Aspazija Sofijanova; Vladimir Avramoski
Journal:  Pediatr Nephrol       Date:  2005-08-05       Impact factor: 3.714

6.  Early biliary pseudolithiasis during ceftriaxone therapy for acute pyelonephritis in children: a prospective study in 34 children.

Authors:  J P Bonnet; L Abid; A Dabhar; A Lévy; Y Soulier; S Blangy
Journal:  Eur J Pediatr Surg       Date:  2000-12       Impact factor: 2.191

7.  Ceftriaxone-associated biliary pseudolithiasis in children.

Authors:  Betül Biner; Naci Oner; Coşkun Celtik; Musa Bostancioğlu; Nermin Tunçbilek; Ahmet Güzel; Serap Karasalihoğlu
Journal:  J Clin Ultrasound       Date:  2006-06       Impact factor: 0.910

8.  Ceftriaxone-associated nephrolithiasis and biliary pseudolithiasis in a child.

Authors:  Jeffrey S Prince; Melvin O Senac
Journal:  Pediatr Radiol       Date:  2003-06-26

9.  Gallbladder and urinary tract precipitations associated with ceftriaxone therapy in children: a prospective study.

Authors:  Ceyda Acun; L Oktay Erdem; Ayhan Söğüt; C Zuhal Erdem; Nazan Tomaç; Sadi Gündoğdu; Serafettin Cavuldak
Journal:  Ann Trop Paediatr       Date:  2004-03

Review 10.  Drug-induced renal calculi: epidemiology, prevention and management.

Authors:  Michel Daudon; Paul Jungers
Journal:  Drugs       Date:  2004       Impact factor: 9.546

View more
  6 in total

1.  Increasing urinary calcium excretion after ceftriaxone and cephalothin therapy in adults: possible association with urolithiasis.

Authors:  Alper Otunctemur; Emin Ozbek; Emre Can Polat; Mustafa Cekmen; Murat Dursun; Suleyman Sami Cakir
Journal:  Urolithiasis       Date:  2013-12-06       Impact factor: 3.436

Review 2.  Drug-Induced Urolithiasis in Pediatric Patients.

Authors:  Maria Chiara Sighinolfi; Ahmed Eissa; Luigi Bevilacqua; Ahmed Zoeir; Silvia Ciarlariello; Elena Morini; Stefano Puliatti; Viviana Durante; Pier Luca Ceccarelli; Salvatore Micali; Giampaolo Bianchi; Bernardo Rocco
Journal:  Paediatr Drugs       Date:  2019-10       Impact factor: 3.022

Review 3.  Characterizing ceftriaxone-induced urolithiasis and its associated acute kidney injury: an animal study and Chinese clinical systematic review.

Authors:  Yifan Zhang; Benxiang Ning; Huaijun Zhu; Xiaoming Cong; Leqing Zhou; Qiang Wang; Liming Zhang; Xizhao Sun
Journal:  Int Urol Nephrol       Date:  2016-04-28       Impact factor: 2.370

4.  Anuria and abdominal pain induced by ceftriaxone-associated ureterolithiasis in adults.

Authors:  Zhao-Lun Li; Hong-Liang Li; Hai-Wen Chen; He-Cheng Li; Peng Zhang; Zi-Ming Wang; Tie Chong
Journal:  Int Urol Nephrol       Date:  2012-11-22       Impact factor: 2.370

5.  Evaluation of hypercalciuria in patients receiving intravenous Cefotaxime.

Authors:  Zahra Kalantari; Parsa Yousefichaijan; Manijeh Kahbazi; Ali Arjmand Shabestari
Journal:  J Family Med Prim Care       Date:  2019-05

6.  Progressive Pseudolithiasis Associated with the Intravenous Administration of Ceftriaxone in Patients with Central Nervous System Infections.

Authors:  Setsuki Tsukagoshi; Kunihiko Ishizawa; Kimitoshi Hirayanagi; Shun Nagamine; Kouki Makioka; Yukio Fujita; Yoshio Ikeda
Journal:  Intern Med       Date:  2017-10-11       Impact factor: 1.271

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.